ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Jan 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
February 2026
Nuclear Technology
January 2026
Fusion Science and Technology
November 2025
Latest News
EDF fleet update has encouraging news for U.K. nuclear industry
The EDF Group’s Nuclear Operations business, which is the majority owner of the five operating and three decommissioning nuclear power plant sites in the United Kingdom, has released its annual update on the U.K. fleet. UK Nuclear Fleet Stakeholder Update: Powering an Electric Britain includes a positive review of the previous year’s performance and news of a billion-dollar boost in the coming years to maximize output across the fleet.
Hungyuan B. Liu
Nuclear Technology | Volume 109 | Number 3 | March 1995 | Pages 314-326
Technical Paper | Fission Reactor | doi.org/10.13182/NT95-A35080
Articles are hosted by Taylor and Francis Online.
A design for a slab reactor to produce an epithermal neutron beam and a thermal neutron beam for use in neutron capture therapy (NCT) is described. A thin reactor with two large-area faces, a “slab” reactor, was planned using eighty-six 20% enriched TRIGA fuel elements (General Atomics, San Diego, California) and four B4C control rods. Two neutron beams were designed: an epithermal neutron beam from one face and a thermal neutron beam from the other. The planned facility, based on this slab-reactor core with a maximum operating power of 300 kW, will provide an epithermal neutron beam of 1.8 × 109 nepi/cm2·s intensity with low contamination by fast neutrons (2.6 × 10−13Gy· cm2/nepi) and gamma rays (<1.0 × 10−13 Gy·cm2/nepi) and a thermal neutron beam of 9.0 × 109 nth/cm2·s intensity with low fast-neutron dose (1.0 × 10−13 Gy·cm2/nth) and gamma dose (<1.0 × 10−13 Gy·cm2/nth). Both neutron beams will be forward directed. Each beam can be turned on and off independently through its individual shutter. A complete NCT treatment using the designed epithermal or thermal neutron beam would take 30 or 20 min, respectively, under the condition of assuming 10 µg 10B/g in the blood. Such exposure times should be sufficiently short to maintain near-optimal target (e.g., 10B, 157Gd, and 235U) distribution in tumor versus normal tissues throughout the irradiation. With a low operating power of 300 kW, the heat generated in the core can be removed by natural convection through a pool of light water. The proposed design in this study could be constructed for a dedicated clinical NCT facility that would operate very safely.